Meredith Ian T
SEC CIK 1693920 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BSX | Boston Scientific | EVP Gbl Chief Med Off | 28.1K | — | $591.0K | 14 | 2021-12-28 | 2022-03-28 |
Most active insiders at BSX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mahoney Michael F | COB, Pres, CEO, Dir | $9.00M | $15.04M |
| 2 | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | — | $9.90M |
| 3 | Zane Ellen M | Dir | — | $2.57M |
| 4 | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | — | $1.76M |
| 5 | LUDWIG EDWARD J | Dir | $430.3K | — |
| 6 | Habiger David C | Dir | $407.9K | — |
| 7 | Morano Susan E | Dir | $100.4K | — |
| 8 | Pegus Cheryl | Dir | $100.0K | — |
| 9 | O'Connor Padraig Andrew | EVP, Gbl Ops | — | — |
| 10 | O'Sullivan Miriam | SVP, Chief HR Off | — | — |
Meredith Ian T made no open-market trades at BSX in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-29 | 2022-03-28 | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | S - Sale | $43.68 | -6,588 | 28.1K | -19% | -$287.8K | |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | M - OptEx | $0.00 | +1,019 | 35.0K | +3% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | F - Tax | $44.17 | -300 | 34.7K | -0.9% | -$13.3K |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | F - Tax | $42.55 | -298 | 34.0K | -0.9% | -$12.7K |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | M - OptEx | $0.00 | +1,013 | 34.2K | +3% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | F - Tax | $42.70 | -672 | 33.2K | -2% | -$28.7K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | M - OptEx | $0.00 | +2,287 | 32.9K | +7% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | M - OptEx | $0.00 | +1,108 | 31.9K | +4% | $0 |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | F - Tax | $44.01 | -326 | 31.6K | -1% | -$14.3K |
| D | 2022-02-02 | 2022-02-01 | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | M - OptEx | $0.00 | +3,131 | 31.8K | +11% | $0 |
| D | 2022-02-02 | 2022-02-01 | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | F - Tax | $43.50 | -919 | 30.8K | -3% | -$40.0K |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | M - OptEx | $0.00 | +3,649 | 29.9K | +14% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | F - Tax | $42.48 | -1,265 | 28.6K | -4% | -$53.7K |
| 2021-12-29 | 2021-12-28 | BSX | Boston Scientific | Meredith Ian T | EVP Gbl Chief Med Off | S - Sale | $43.21 | -7,018 | 26.2K | -21% | -$303.2K |
Purchase Sale Sale after option exercise All abbreviations